Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


Cell Based Assays

18 Nov 2013 - 19 Nov 2013 - London, UK



Bookmark and Share


SMi is proud to present their 6th Annual...

Cell Based Assays

Following on from our hugely successful Cell-Based Assays conference in 2012, this year's agenda will provide a global forum for senior level decision makers and those working within Cell-Based Assays to meet.

Highly accurate in-vitro practices are becoming absolutely vital as is looking at cost-effective assay development. Cell based assays now play an important role into the research pipeline, making a large percentage of total research time and is set to show considerable growth over the coming years.

There are currently 15 FDA approved kinase inhibitor drugs, but there currently remains a huge uncapped potential with these drugs as over 90% of the kinome is unknown. Novel assays have identified kinase targets, improved the function of kinase inhibitors and led to an acceleration in drug discovery with new inhibitor classes.

See at Cell Based Assays 2013 how HCA can be utilised in your pre-clinical toxicology procedures to give highly accurate data.

WHY ATTEND THIS EVENT: 

Hear the latest on Phenotypic screening; how target based screening is allowing for identification of small molecules

See how you can implement a primary cell assay plan through a case study of SARdriving assay

The latest in GPCR and other ion channel targeting pathways and how they are being used in the most recent drug discovery assays

Adopt accelerated primary cell screening systems such as those utilised by GSK

KEYNOTE SPEAKERS INCLUDE:

Mao Xiang Chen, Biological and Cellular targets, GlaxoSmithKline

Martha Brown, Senior Associate Director, Boehringer-Ingelheim

Xavier Leroy, Director, Actelion

Steve Ludbrook, Section Head, GlaxoSmithKline

Urs Luethi, Senior Lab Head Discovery, Actelion

Anthony Davies, Director, Trinity College Dublin

Tyrell Norris, Team Leader – Cellular Reagents & Assay Development, AstraZeneca

Amir Gander, Senior Knowledge Transfer Associate, University College London

**Book by 19th July 2013 and save £300**

**Book by 31st September 2013 and save £100**

Visit our website here:  http://ww.smi-online.co.uk/goto/2013cellbasedassay20.asp

Alternatively, contact Fateja Begum on +44 (0)20 7827 6184 or email:  fbegum@smi-online.co.uk



Further information
Scientific News
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!